Holen Sie sich die Stockscreener-App
15.06
0.40%
0.06
Handel nachbörslich:
15.06
Schlusskurs vom Vortag:
$15.00
Offen:
$14.86
24-Stunden-Volumen:
26,223
Relative Volume:
0.48
Marktkapitalisierung:
$395.33M
Einnahmen:
$59,000
Nettoeinkommen (Verlust:
$-21.81M
KGV:
-1.3751
EPS:
-10.9518
Netto-Cashflow:
$-18.07M
1W Leistung:
+9.29%
1M Leistung:
+8.74%
6M Leistung:
+13.49%
1J Leistung:
+48.23%
1-Tages-Spanne:
$14.58
$15.12
1-Wochen-Bereich:
$13.63
$15.31
52-Wochen-Spanne:
$9.10
$17.15
Benitec Biopharma Inc Stock (BNTC) Company Profile
Firmenname
Benitec Biopharma Inc
Sektor
Branche
Telefon
(510) 780-0819
Adresse
3940 TRUST WAY, HAYWARD, CA
Vergleichen Sie BNTC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BNTC
Benitec Biopharma Inc
|
15.06 | 393.76M | 59,000 | -21.81M | -18.07M | -10.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Benitec Biopharma Inc Stock (BNTC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-07 | Eingeleitet | TD Cowen | Buy |
| 2024-12-16 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-12-13 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-10-16 | Eingeleitet | Oppenheimer | Outperform |
| 2024-09-12 | Eingeleitet | Guggenheim | Buy |
| 2024-07-22 | Eingeleitet | Leerink Partners | Outperform |
| 2024-06-13 | Eingeleitet | Piper Sandler | Overweight |
| 2020-10-05 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2020-04-20 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2016-02-26 | Herabstufung | Maxim Group | Buy → Hold |
| 2015-12-31 | Bestätigt | Maxim Group | Buy |
| 2015-09-16 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Benitec Biopharma Inc Aktie (BNTC) Neueste Nachrichten
Forecasting Benitec Biopharma Inc. price range with options data2025 Top Gainers & Trade Opportunity Analysis - newser.com
Is Benitec Biopharma Inc. stock positioned well for digital economy2025 Trading Recap & Intraday High Probability Setup Alerts - newser.com
Using economic indicators to assess Benitec Biopharma Inc. potentialQuarterly Earnings Report & Consistent Profit Trading Strategies - newser.com
Real time social sentiment graph for Benitec Biopharma Inc.July 2025 Big Picture & Accurate Intraday Trading Signals - newser.com
What sentiment indicators say about Benitec Biopharma Inc. stockWeekly Trend Summary & AI Enhanced Market Trend Forecasts - newser.com
Using AI based signals to follow Benitec Biopharma Inc.2025 Technical Patterns & Safe Capital Preservation Plans - newser.com
Will Benitec Biopharma Inc. stock go up soonWeekly Risk Report & Community Consensus Picks - newser.com
Is Benitec Biopharma Inc a good long term investmentEquity Performance Review & Trusted Financial Advisors at No Cost - earlytimes.in
What’s the recovery path for long term holders of Benitec Biopharma Inc.July 2025 Sentiment & Stepwise Trade Execution Plans - newser.com
Weiss Ratings Reiterates "Sell (D-)" Rating for Benitec Biopharma (NASDAQ:BNTC) - MarketBeat
What Fibonacci levels say about Benitec Biopharma Inc. reboundJuly 2025 Spike Watch & Technical Pattern Based Buy Signals - newser.com
Benitec Biopharma (NASDAQ:BNTC) Stock Rating Lowered by Zacks Research - MarketBeat
Using Ichimoku Cloud for Benitec Biopharma Inc. technicals2025 Fundamental Recap & High Accuracy Investment Signals - newser.com
Is Benitec Biopharma Inc. stock reversal real or fake2025 Volatility Report & Free Technical Confirmation Trade Alerts - newser.com
Intraday pattern recognizer results for Benitec Biopharma Inc.2025 Support & Resistance & Safe Entry Trade Signal Reports - newser.com
What indicators show strength in Benitec Biopharma Inc.July 2025 Opening Moves & Free Weekly Chart Analysis and Trade Guides - newser.com
Leading vs lagging indicators on Benitec Biopharma Inc. performanceGap Down & Comprehensive Market Scan Insights - newser.com
Will Benitec Biopharma Inc. see short term momentumJuly 2025 News Drivers & Consistent Growth Stock Picks - newser.com
Where Analysts See Genomic Valley Biotech Limited Stock by YearEndMonthly Performance Summary & Bull Bear Market Updates - earlytimes.in
Published on: 2025-10-03 03:21:02 - newser.com
Backtesting results for Benitec Biopharma Inc. trading strategiesSwing Trade & Weekly Hot Stock Watchlists - newser.com
Applying big data sentiment scoring on Benitec Biopharma Inc.Bull Run & Free Safe Entry Trade Signal Reports - newser.com
Benitec Biopharma Limited (NASDAQ:BNTC) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat
Published on: 2025-09-30 04:03:09 - newser.com
How to build a custom watchlist for Benitec Biopharma Inc.Bull Run & Fast Momentum Entry Tips - newser.com
How to interpret RSI for Benitec Biopharma Inc. stockQuarterly Trade Review & Risk Controlled Daily Plans - newser.com
Finanzdaten der Benitec Biopharma Inc-Aktie (BNTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Benitec Biopharma Inc-Aktie (BNTC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Mar 26 '25 |
Buy |
13.00 |
900,000 |
11,700,000 |
8,793,245 |
| BUCHI J KEVIN | Director |
Feb 27 '25 |
Option Exercise |
3.86 |
51,813 |
199,998 |
103,910 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 23 '24 |
Buy |
10.98 |
27,502 |
301,972 |
7,981,725 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 24 '24 |
Buy |
11.25 |
20,018 |
225,202 |
7,999,455 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 03 '24 |
Buy |
9.60 |
42,000 |
403,200 |
7,957,365 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Nov 20 '24 |
Buy |
10.22 |
27,436 |
280,396 |
7,920,175 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Nov 19 '24 |
Buy |
9.73 |
14,000 |
136,220 |
7,895,815 |
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):